TYMS overexpression is associated with poor disease-specific survival and local recurrence-free survival of various solid tumors such as lung cancer (Ding et al.,2020), gastric cancer (Cao et al.,2017) and prostate cancer (Burdelski et al.,2015). Here, TYMS is linked to prostate cancer.